Fundamental Analysis Stories

JOUT
  over three months ago at Macroaxis 
By Raphi Shpitalnik
Johnson Outdoors Market Capitalization is comparatively stable at the moment as compared to the past year. Johnson Outdoors reported Market Capitalization of 364.77 Million in 2020. Tangible Asset Value is likely to gain to about 329 M in 2021, whereas Interest Coverage is likely to drop 28.63 in 2021. If you have been following Johnson you may be considering acquiring. Let's check if stable basic indicators will continue to push the price to gain for Johnson Outdoors' private investors. Johnson Outdoors current chance of bankruptcy is under 1 percent. Will private investors continue to be optimistic, or should we expect a sell-off?
AME
  over three months ago at Macroaxis 
By Ellen Johnson
AMETEK Long Term Debt to Equity is projected to increase slightly based on the last few years of reporting. The past year's Long Term Debt to Equity was at 0.51. The current year Calculated Tax Rate is expected to grow to 26.61, whereas Revenue Per Employee is forecasted to decline to about 241 K. AMETEK Inc is scheduled to announce its earnings today. The next earnings report is expected on the 4th of May 2021. Although many conservative investors are getting more into industrials space, we should study AMETEK's latest fundamentals in more details. We will evaluate why we are still confident in anticipation of a recovery. We currently estimate AMETEK as undervalued. The real value is approaching 124.84 per share.
BMY
  over three months ago at Macroaxis 
By Gabriel Shpitalnik
Bristol Myers Book Value per Share is fairly stable at the moment as compared to the past year. Bristol Myers reported Book Value per Share of 36.42 in 2020. Dividend Yield is likely to rise to 0.0248 in 2021, whereas Net Income Per Employee is likely to drop slightly above 100.7 K in 2021. If you are looking to grow your portfolio over time, you may want to break down all of the essential basic indicators of your selected equities before buying their shares. In this article, we will break down Bristol Myers. We will analyze why Bristol Myers investors may still consider a stake in the business. We currently estimate Bristol Myers as undervalued. The real value is approaching 67.92 per share.
ETN
  over three months ago at Macroaxis 
By Vlad Skutelnik
Eaton PLC Cash and Equivalents is quite stable at the moment as compared to the past year. The company's current value of Cash and Equivalents is estimated at 386.46 Million. Debt Current is expected to rise to about 722.3 M this year, although the value of Average Assets will most likely fall to about 36 B. Despite quite persistent basic indicators, Eaton PLC is not utilizing all of its potentials. The latest stock price mess, may contribute to a short-term swings for the institutional investors. Eaton PLC probability of distress is under 27 percent. Will the entity institutional investors continue to acquire in March?
GPK
  over three months ago at Macroaxis 
By Achuva Shats
Graphic Packaging Calculated Tax Rate is increasing as compared to previous years. The last year's value of Calculated Tax Rate was reported at 19.40. The current PPandE Turnover is estimated to increase to 2.58, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are projected to decrease to under 898.5 M. Graphic Packaging is scheduled to announce its earnings today. The next earnings report is expected on the 20th of April 2021. As many risky investors are excited about consumer cyclical space, it is only fair to examine Graphic Packaging Holding based on its current volatility. We will evaluate why recent Graphic Packaging price moves suggest a bounce in March. Will traders continue to hold, or should we expect a sell-off?
TMO
  over three months ago at Macroaxis 
By Raphi Shpitalnik
Thermo Fisher Invested Capital is quite stable at the moment as compared to the past year. The company's current value of Invested Capital is estimated at 16.18 Billion. Invested Capital Average is expected to rise to about 16.3 B this year, although the value of Net Income Per Employee will most likely fall to about 38.2 K. If you have been following Thermo you may be considering picking up. Let's check if persistent primary indicators will continue to push the price to rise for Thermo Fisher's institutional investors. The entity current odds of financial turmoil is under 1 percent. Will institutional investors continue to be optimistic, or should we expect a sell-off?
HLIT
  over three months ago at Macroaxis 
By Gabriel Shpitalnik
Harmonic Accounts Payable Turnover is comparatively stable at the moment as compared to the past year. Harmonic reported Accounts Payable Turnover of 12.40 in 2020. Operating Margin is likely to gain to 4.03 in 2021, whereas Enterprise Value is likely to drop slightly above 606.3 M in 2021. If you are looking to grow your portfolio over time, you may want to review all of the essential basic indicators of your selected equities before buying their shares. In this article, we will review Harmonic. We will analyze why Harmonic investors may still consider a stake in the business. Will private investors continue to hold, or should we expect a sell-off?
ICON
  over three months ago at Macroaxis 
By Ellen Johnson
Despite quite inconsistent forward indicators, Iconix Brand disclosed solid returns over the last few months and may actually be approaching a breakup point. Iconix Brand Group chance of bankruptcy is under 38 percent. Will Iconix Brand institutional investors continue to buy in March?
NSC
  over six months ago at Macroaxis 
By Raphi Shpitalnik
Norfolk Southern Calculated Tax Rate is projected to decrease significantly based on the last few years of reporting. The past year's Calculated Tax Rate was at 25.33. The current year PPandE Turnover is expected to grow to 0.45, whereas Net Income Per Employee is forecasted to decline to about 87.1 K. Despite somewhat strong basic indicators, Norfolk Southern is not utilizing all of its potentials. The recent stock price disturbance, may contribute to a short-term swings for the investors. Will investors continue to hold, or should we expect a sell-off?
HXL
  over six months ago at Macroaxis 
By Vlad Skutelnik
Hexcel Return on Investment is relatively stable at the moment as compared to the past year. The company's current value of Return on Investment is estimated at 21.38. Revenue to Assets is expected to hike to 0.96 this year, although the value of Revenue Per Employee will most likely fall to nearly 294 K. Even with relatively steady technical and fundamental indicators, Hexcel is not utilizing all of its potentials. The current stock price chaos, may contribute to a medium-term swings for the stakeholders. We currently estimate Hexcel as overvalued. The real value is approaching 44.55 per share.